RLAY - Financial Reports List - Relay Therapeutics, Inc. - IntrinsicAlpha

Relay Therapeutics, Inc. RLAY

Healthcare - Biotechnology - NASDAQ - US

$ 2.8693

2.23 %

$ 486 M

Market Cap

-1.17

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	100.00%	8.97%	7.83%
Annual Report	FY	10-K	2024-12-31	-60.83%	1.25%	0.14%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-34.03%	-30.98%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	6.39%	-5.73%
Quarterly Report	Q1	8-K	2024-03-31	4327.88%	6.77%	8.88%
Quarterly Report	Q4	8-K	2023-12-31	-0.40%	-92.76%	-26.55%
Annual Report	FY	10-K	2023-12-31	1749.82%	-34.50%	-24.63%
Quarterly Report	Q3	8-K	2023-09-30	7226.16%	24.67%	14.34%
Quarterly Report	Q2	8-K	2023-06-30	-67.40%	-28.28%	-36.29%
Quarterly Report	Q1	8-K	2023-03-31	-46.06%	-69.57%	-61.31%

1